APA (7th ed.) Citation

ZF, C., BJ, W., R, H., JE, R., JT, F., KK, W., . . . N, C. (2021). The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia. Science translational medicine, 13(607), . https://doi.org/10.1126/scitranslmed.abd3904

Chicago Style (17th ed.) Citation

ZF, Caffall, et al. "The HIV Protease Inhibitor, Ritonavir, Corrects Diverse Brain Phenotypes Across Development in Mouse Model of DYT-TOR1A Dystonia." Science Translational Medicine 13, no. 607 (2021). https://doi.org/10.1126/scitranslmed.abd3904.

MLA (9th ed.) Citation

ZF, Caffall, et al. "The HIV Protease Inhibitor, Ritonavir, Corrects Diverse Brain Phenotypes Across Development in Mouse Model of DYT-TOR1A Dystonia." Science Translational Medicine, vol. 13, no. 607, 2021, https://doi.org/10.1126/scitranslmed.abd3904.